HIMENSION CAPITAL (SINGAPORE) PTE. LTD.

Position in CRSP — CRISPR Therapeutics AG

CIK 1817652 SINGAPORE, U0

Position in CRSP

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$4,575,742

+$176,421 QoQ

Shares Held

83,897

-9.3% QoQ

Ownership

0.087%

of shares outstanding

% of Portfolio

0.28%

of 13F equity value

Holder Rank

#78

of 519 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HIMENSION CAPITAL (SINGAPORE) PTE. LTD. holds $26,011,934 across 20 Biotechnology names. CRSP ranks #3 (17.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NTLA	Intellia Therapeutics, Inc.	326,893	$5,531,029
2	ALNY	Alnylam Pharmaceuticals, Inc.	18,136	$5,459,480
3	CRSP	CRISPR Therapeutics AG This page	83,897	$4,575,742
4	MRNA	Moderna, Inc.	25,218	$1,766,016
5	BEAM	Beam Therapeutics Inc.	36,419	$1,249,900
6	RVMD	Revolution Medicines, Inc.	5,653	$1,058,693
7	RLAY	Relay Therapeutics, Inc.	50,111	$937,576
8	ABVX	Abivax S.A.	4,591	$611,796

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,575,742	83,897	-9.3%	Shares	Sole	2026-08-13
2026-03-31	$4,399,321	92,481	+9.6%	Shares	Sole	2026-05-12
2025-12-31	$4,425,411	84,390	+16.7%	Shares	Sole	2026-02-17
2025-09-30	$4,688,290	72,339	-13.0%	Shares	Sole	2025-11-13
2025-06-30	$4,042,956	83,120	-11.2%	Shares	Sole	2025-08-13
2025-03-31	$3,184,323	93,574	+15.9%	Shares	Sole	2025-05-14
2024-12-31	$3,179,107	80,770	-0.5%	Shares	Sole	2025-02-13
2024-09-30	$3,812,192	81,145	+4.6%	Shares	Sole	2024-11-13
2024-06-30	$4,188,043	77,542	+12.4%	Shares	Sole	2024-08-13
2024-03-31	$4,704,062	69,015	0.0%	Shares	Sole	2024-05-14
2023-12-31	$4,320,339	69,015	-63.4%	Shares	Sole	2024-02-14
2021-09-30	$21,113,803	188,634	+19.9%	Shares	Sole	2021-11-10
2021-06-30	$25,470,801	157,334	—	Shares	Sole	2021-08-03
No filing history on record for this holder in this stock.